Betoptic Suspension 2.5 mg/ml · CNK 1073899

Product information

Betoptic Suspension 2.5 mg/ml
5 ml
1073899
8.18 / 10
Locked

Product properties

S01ED02
Novartis Pharma
Eye drops, suspension
BE160334
07612797422700
M1
Public
160334-01

Pharmacist Assessment

Discontinued product — remaining stock available

The commercialization of this product has been stopped (reason: Commercial reasons), but remaining stock is available at wholesalers (score 8.18/10). This stock will not be replenished. Plan the switch to an alternative.

No available alternative found in the system. Consult the physician for a therapeutic alternative.

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 16 of 18 warehouse locations have stock
  • 3 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Commercial reasons

Adaptation of the treatment is possible
Available
Until 30/07/2026

Composition

7 ingredients

Substance Type Strength CAS
Active ingredient
2.8 mg/g
63659-19-8
Excipient
Excipient
4 mg/mL
Excipient
0.1 mg
Excipient
45 mg/mL
Excipient
Excipient
2.5 mg/mL

Additional information

View on BCPI

Availability statistics

Commercialization stopped
91 days
5
0
31/07/2026